Literature DB >> 17557564

In vivo evaluation of melanoma thickness by multispectral imaging and an artificial neural network. A retrospective study on 250 cases of cutaneous melanoma.

Renato Marchesini1, Aldo Bono, Stefano Tomatis, Cesare Bartoli, Ambrogio Colombo, Manuela Lualdi, Mauro Carrara.   

Abstract

AIMS AND
BACKGROUND: Noninvasive diagnostic methods such as dermoscopy, sonography, palpation or combined approaches have been developed in an attempt to preoperatively estimate melanoma thickness. However, the clinical presentation is often complex and the evaluation subjective. Multispectral image analysis of melanomas allows selection of features related to the content and distribution of absorbers, mainly melanin and hemoglobin, present within the lesion. Hence, it is reasonable to assume that the same features might be useful to predict melanoma thickness.
METHODS: A multispectral image system was used to analyze in vivo 1939 pigmented skin lesions. The lesion selection was based on clinical and/or dermoscopic features that supported a suspicion for melanoma. All the lesions were then subjected to surgery for the histopathological diagnosis, and 250 were melanomas. From the multispectral images of the melanomas, we selected 12 features, seven of which were used to train and test an artificial neural network on 155 and 95 melanomas, respectively.
RESULTS: Sensitivity (i.e., melanoma > or = 0.75 mm thick correctly classified) and specificity (i.e., melanoma < 0.75 mm thick correctly classified) evaluated from the receiving operating characteristic curves ranged from 76 to 90% and from 91 to 74%, respectively.
CONCLUSIONS: Our approach provides results similar to those obtained with other methods and has the advantage that it is not related to the expertise of the clinician. In addition, the physical interpretation of the selected features suggests a possible role of spectrophotometry as an objective method to study the natural history of the early phases of the disease.

Entities:  

Mesh:

Year:  2007        PMID: 17557564     DOI: 10.1177/030089160709300210

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  4 in total

1.  The role of spectrophotometry in the diagnosis of melanoma.

Authors:  Paolo A Ascierto; Marco Palla; Fabrizio Ayala; Ileana De Michele; Corrado Caracò; Antonio Daponte; Ester Simeone; Stefano Mori; Maurizio Del Giudice; Rocco A Satriano; Antonio Vozza; Giuseppe Palmieri; Nicola Mozzillo
Journal:  BMC Dermatol       Date:  2010-08-13

Review 2.  Current and emerging technologies in melanoma diagnosis: the state of the art.

Authors:  Estee L Psaty; Allan C Halpern
Journal:  Clin Dermatol       Date:  2009 Jan-Feb       Impact factor: 3.541

3.  Multispectral Imaging Algorithm Predicts Breslow Thickness of Melanoma.

Authors:  Szabolcs Bozsányi; Noémi Nóra Varga; Klára Farkas; András Bánvölgyi; Kende Lőrincz; Ilze Lihacova; Alexey Lihachev; Emilija Vija Plorina; Áron Bartha; Antal Jobbágy; Enikő Kuroli; György Paragh; Péter Holló; Márta Medvecz; Norbert Kiss; Norbert M Wikonkál
Journal:  J Clin Med       Date:  2021-12-30       Impact factor: 4.241

4.  Band selection in spectral imaging for non-invasive melanoma diagnosis.

Authors:  Ianisse Quinzán; José M Sotoca; Pedro Latorre-Carmona; Filiberto Pla; Pedro García-Sevilla; Enrique Boldó
Journal:  Biomed Opt Express       Date:  2013-03-04       Impact factor: 3.732

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.